XML 42 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Other income
 12 Months Ended
Dec. 31, 2022
Other income
NOTE 16—Other income:
 
 
  
Year ended December 31,
 
 
  
  2022  
 
  
  2021  
 
  
  2020  
 
 
  
(U.S. $ in millions)
 
Gain on divestitures, net of divestitures related costs (1)
    $ 46        51        8  
Section 8 and similar payments (2)
      13        19        —    
Gain (loss) on sale of assets
      18        7        11  
Other, net (3)

      31        22        20  
    
 
 
     
 
 
     
 
 
  
Total other income
    $ 107      $ 98      $ 40  
    
 
 
     
 
 
     
 
 
  
 
(1)
In 2022, mainly related to the divestment of several activities in North America and International Markets. In 2021, mainly due to capital gains related to the sale of certain OTC assets. In 2020, mainly related to the divestment of several activities in International Markets.
(2)
Section 8 of the Patented Medicines (Notice of Compliance) Regulation relates to recoveries of lost revenue related to patent infringement proceedings in Canada.
(3)
In 2022, mainly the result of settlement proceeds related to the International Markets segment.